HomeSKYE • NASDAQ
add
Skye Bioscience Inc
Previous close
$3.10
Day range
$2.61 - $3.10
Year range
$2.31 - $17.65
Market cap
84.04M USD
Avg Volume
186.87K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.97M | 42.37% |
Net income | -3.90M | 84.37% |
Net profit margin | — | — |
Earnings per share | -0.10 | — |
EBITDA | -4.90M | -41.65% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 67.41M | 1,215.05% |
Total assets | 81.54M | 422.52% |
Total liabilities | 5.73M | -58.79% |
Total equity | 75.80M | — |
Shares outstanding | 30.34M | — |
Price to book | 1.24 | — |
Return on assets | -14.72% | — |
Return on capital | -16.15% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -3.90M | 84.37% |
Cash from operations | -5.26M | -29.79% |
Cash from investing | -1.45M | -234.71% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -6.71M | -149.13% |
Free cash flow | -6.06M | 46.62% |
About
Founded
2011
Website
Employees
11
